Weekly Recap: 14 Health Press Releases You Need to See

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including AI-powered dream reconstruction, veterans' health at the Indy 500 and the first generic version of Tasigna(®).

NEW YORK, May 30, 2025 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed.

The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download.

    1. Lilly To Expand Its Pain Pipeline With Acquisition of SiteOne
       Therapeutics "The global burden of chronic pain continues to increase,
       and an effective non-opioid treatment remains elusive," said Mark Mintun,
       Lilly group vice president Neuroscience Research and Development. "Lilly
       is eager to continue the development of STC-004 with the outstanding
       SiteOne team as part of our efforts to advance novel, addiction-free pain
       therapies."

    2. INDY 500 Stars Join Forces with ZERO Prostate Cancer to Put Veterans'
       Health in the Spotlight at Memorial Day Weekend Races In partnership with
       Juncos Hollinger Racing, ZERO's logo was featured on two cars in the
       109th Running of the Indianapolis 500--the world's biggest single-day
       sporting event--on Sunday, May 25. The message? Veterans are twice as
       likely to face prostate cancer--and early detection saves lives.

    3. Shaklee Continues to Expand Its Innovative Wellness Product Offering
       Through New Acquisition The acquisition includes Modere's rights to all
       the trademarks, patents, and formulas for all Modere products including
       Liquid BioCell(®) Collagen and Trim - the two most popular product lines
       in the Modere portfolio. The acquisition also includes all the
       manufacturing and testing equipment in Modere's North American
       manufacturing facilities and all related inventory.

    4. Gilgamesh Pharmaceuticals Announces Positive Topline Phase 2a Results for
       GM-2505 in Major Depressive Disorder (MDD)"The clinical response and
       remission rates highlight the potential for GM-2505 to be a
       groundbreaking therapy for patients with MDD," said Jonathan Sporn, MD,
       Founder and CEO of Gilgamesh Pharmaceuticals. "GM-2505's rapid and
       sustained antidepressant effect fits seamlessly into the existing
       two-hour in-clinic treatment model."

    5. Valeris Launches with a Fully Integrated Vision for Life Sciences
       Companies By uniting capabilities that deliver value throughout the
       commercialization process - data and strategic insights, patient support
       services, and healthcare provider engagement tools, Valeris represents a
       bold commitment to a better patient experience by streamlining access,
       reducing barriers, and supporting adherence.

    6. UniXell Biotechnology announces the first patient dosed with UX-DA001, an
       investigational autologous iPSC based cell therapy for the treatment of
       Parkinson's Disease, in Its Phase 1 studyThe first recipient of UniXell's
       autologous stem cell-derived drug, UX-DA001, shared, "after receiving the
       stem cell treatment, I experienced a remarkable improvement in my sleep
       quality. I fall asleep quickly and notice gradual progress every day.
       Although recovery takes time, the 'day by day improvement' fills me with
       hope for the future."

    7. The Sandlot Star Patrick Renna Teams Up with Dramamine(®) to Revisit an
       Iconic Scene - This Time, Puke FreeThe Advanced Herbals(TM) supplement
       line by the makers of Dramamine(®) is giving Americans the chance to win
       a vacation do-over, this time with Ginger Chews as a solution for
       unwelcome nausea.

    8. Coalesce Capital Acquires Leading Healthcare IT and Business Solutions
       Provider DAS Health DAS Health provides a comprehensive suite of IT,
       cybersecurity, revenue cycle management, and business solutions to
       thousands of healthcare organizations across North America, streamlining
       workflows, increasing productivity, and improving patient care. Coalesce
       will support DAS Health's growth by investing in technology, talent, and
       strategic acquisitions, further strengthening the company's ability to
       deliver value to healthcare organizations.

    9. Celltrion's YUFLYMA(®) (adalimumab-aaty) receives FDA interchangeability
       designation for all Its approved dosage forms and strengths "This full
       interchangeability designation comes at a pivotal time as Celltrion
       continues to lead in the evolving biosimilar landscape," said Thomas
       Nusbickel, Chief Commercial Officer at Celltrion USA. "YUFLYMA - a
       high-concentration, citrate-free adalimumab biosimilar now fully
       interchangeable with Humira - reflects our long-standing commitment to
       delivering high-quality, accessible treatment options."

    10. Pillar Biosciences Raises $34.5M in FundingProceeds from this financing
        will be leveraged to advance Pillar's commercial activities including
        headcount and infrastructure to support biopharma partnerships and
        expand adoption of its distributable clinical testing kits.

    11. START and OneOncology Partner To Expand Access to Early Phase Oncology
        Trials This strategic partnership directly addresses the critical need
        to expand access to innovative cancer therapies in community practices,
        where the majority of cancer patients receive care but have historically
        had access to fewer than 20% of early phase clinical trials.

    12. Apotex launches nilotinib capsules, the first generic version of
        Tasigna(®) in the United States, with 180 days of exclusivity "By
        offering the first generic version of this important leukemia treatment,
        we improve access and outcomes for both adult and pediatric patients
        facing this serious disease," said Christine Baeder, President, Apotex
        USA.

    13. O'Shaughnessy Ventures Backs AI-Powered Dream Reconstruction Ninon Lizé
        Masclef will use the fellowship to develop a prototype brain-computer
        interface that uses artificial intelligence to convert raw brain-wave
        data into immersive, 3D reconstructions of dreams. She will present her
        findings at a scientific conference and use the work as the foundation
        for a broader initiative to decode the subconscious through neural
        interfaces.

    14. New Strategic Partnership Between ConnectureDRX and EvolveNXT Unifies
        Agent Onboarding, Enrollment, and Commissions This collaboration brings
        together two industry-leading platforms to create a seamless, end-to-end
        experience for health plans, agencies, and their producers, streamlining
        everything from onboarding to enrollments to commissions. It reflects
        both companies' commitment to exceptional client experience and to
        solving Medicare's complex challenges with innovative technology that
        empowers agents and simplifies compliance.

For more news like this, check out all of the latest health-related releases from PR Newswire.

Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most.

Helping Journalists Stay Up to Date on Industry News

These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists.

Once they're signed up, reporters, bloggers, and freelancers have access to the following free features:

    --  Customization: Users can create customized newsfeeds that will deliver
        relevant news right to their inbox. Newsfeed results can be targeted by
        keywords, industry, subject, geography, and more.
    --  Photos and Videos: Thousands of multimedia assets are available to
        download and include in a journalist or blogger's next story.
    --  Subject Matter Experts: Journalists will have access to ProfNet, a
        database of industry experts to connect with as sources or for quotes in
        their articles.
    --  Related Resources: Our journalist- and blogger-focused blog, Beyond
        Bylines, features regular media news roundups, writing tips, upcoming
        events, and more.

About PR Newswire

PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

For questions, contact the team at media.relations@cision.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/weekly-recap-14-health-press-releases-you-need-to-see-302468891.html

SOURCE PR Newswire